What Is It?
Sanofi is committed to collaborating with partners to advance cutting-edge discoveries. The Sanofi Innovations in Data Exploration and Analytics (iDEA) Awards program, launched in 2018, provides seed funding to innovators at research centers and early start-ups across North America to transform breakthrough digital, data science tools and new technologies into solutions that accelerate the R&D pipeline and improve people’s lives. In 2022, the iDEA awards (NA) and iTECH awards (Europe) merged into the Sanofi global iDEA-TECH awards.
Sanofi iDEA-TECH Awards 2023
Recent award recipients share how winning this award and collaborating with Sanofi researchers has impacted their work.
About the Program
- Seed funding of $150.000 USD
- 1 year project duration
- Dedicated Sanofi Project Champion and resources (subject matter experts)
- A stepping stone to further collaboration
The Sanofi iDEA-TECH Awards 2024 call for projects is now closed.
The next call will be launched at the end of 2025.
Examples of Partnering Opportunities
Predict patient outcomes
Predict & track disease progression & drug effects
Maximize drug value in the real world
Optimize clinical trial design
Drug target enabling platforms
Biomarker Identification
Test new digital/AI solutions
High throughput screening approaches
Analytic tools to understand drug mechanism or product quality
Testimonials
“The iDEA-TECH Awards initiative is providing a unique opportunity to work as a team to study itch in kids with atopic dermatitis in the comfort of their homes by incorporating our Emerald AI technology. It has been exciting to work so closely with the Sanofi team around a shared commitment to breaking new grounds for this important population.”
Dina Katabi, PhD, Thuan and Nicole Pham Professor, MIT President and co-Founder, Emerald Innovations, Inc.
iDEA-TECH Recipients for the 2024-2025 Cycle
Mark Levin, PhD
The University of Chicago
Norman Wagner, PhD
University of Delaware
Shannon Stahl, PhD
The Board of Regents of the University of Wisconsin System
Louis-Charles Fortier, PhD
Universite de Sherbrooke
Shane Byrne, PhD
Codomax
Haiqing Bai, PhD
Xellar, Inc.
Timothy Dunn, PhD
dance.ai, INC
Steve Xu, MD
Sibel Health
Xia Ning, PhD, MBA
The Ohio State University
Regina Barzilay, PhD
MIT
Mohammad Alexanderani, MD
Weill Cornell Medicine
Yaping Liu, PhD and Zongqi Xia MD, PhD
Northwestern University Feinberg School of Medicine
Yonatan Winetraub, PhD and Kavita Sarin, MD
Stanford University
Joint Publications
Learning the Language of Antibody Hypervariability
MIT, Berger, 2024
Disease Progression Strikingly Differs in Research and Real-World Parkinson’s Populations
Harvard Medical School, Brett Beaulieu-Jones and Isaac Kohane, 2024